Global Home Global Home  
 
 

 

 

Investor FAQs

What does Sonoma Pharmaceuticals do?

Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.oculusis.com.

Who are Sonoma Pharmaceuticals customers?

It is currently a mix of dermatologists and wound care doctors/nurses.

When was Oculus Innovative Sciences founded?

We were incorporated in California in 1999 as Micromed Laboratories, Inc. In August 2001, we changed our name to Oculus Innovative Sciences, Inc. In December 2006, we reincorporated in Delaware.

Where is Sonoma Pharmaceuticals located??

Our principal executive offices are located at:

1129 N. McDowell Blvd.

Petaluma, California 94954

Tel: (707) 782-0792.

We have a subsidiary: Oculus Technologies of Mexico, S.A. de C.V., organized in Mexico.

How many employees does Oculus have?

As of March 2015, 75 full-time employees globally.

When was Sonoma Pharmaceuticals' initial public offering, and what was the offering price?

Oculus Innovative Sciences, Inc. went public on January 25, 2007 and the offering price was $8.00 per share.

What is the company's CUSIP number?

Sonoma Pharmaceuticals' CUSIP number is 67575P10

What is Sonoma Pharmaceuticals' stock symbol and on what stock exchange is it listed?
Oculus' stock symbol is SNOA (warrants: SNOAW) and is listed on the Nasdaq Global Market system.
When is Sonoma Pharmaceuticals' fiscal quarter and year-end dates?

Sonoma Pharmaceuticals operates on a fiscal year ending March 31st. Our quarterly reporting periods end on June 30th, September 30th, December 31st and March 31st.

Who is Sonoma Pharmaceuticals' transfer agent and how does a registered shareholder contact the agent regarding account information?

Sonoma Pharmaceuticals' transfer agent is:
Computershare, Inc.

By Regular Mail
P.O. BOX 30170 College Station, TX 77842

By Overnight Delivery
211 Quality Circle Suite 210 College Station, TX 77845

Toll Free 888 647 8901
Toll +1 (201) 680 6578

If I own certificated shares of Sonoma Pharmaceuticals and have misplaced my stock certificate, what can I do?

You can contact Sonoma Pharmaceuticals' transfer agent, Computershare

I've recently moved. How do I submit my new address?

You must contact our transfer agent, Computershare

Who are the auditors of Sonoma Pharmaceuticals?

Marcum & Kliegman LLP, New York, New York

Who is the company's outside legal counsel?

Amy Trombly, Esq.
Trombly Business Law, PC
(617) 243-0060

Does Sonoma Pharmaceuticals currently offer a direct stock purchase plan?

The company does not offer a direct stock purchase program.

Does Sonoma Pharmaceuticals pay a cash dividend on its shares of common stock?

We have never paid our stockholders cash dividends, and we do not anticipate paying any cash dividends in the foreseeable future as we intend to retain any earnings for use in our business.

Who are the Sonoma Pharmaceuticals Officers & Directors?

Oculus's officers and directors can be found on the Corporate Governance page of the investor relations Web site.

How can I contact someone at Sonoma Pharmaceuticals with a question or request?

Please visit the Contact Us page on the Company website. Email addresses for specific questions and concerns are provided. Additionally, Sonoma Pharmaceuticals can be reached by calling 707-782-0792.

How can I find information on Sonoma Pharmaceuticals filings?

Oculus's SEC filings can be obtained by visiting SEC Filings page or www.sec.gov.

Who handles investor relations for Sonoma Pharmaceuticals?

Investor relations is handled by Sonoma Pharmaceuticals' internal staff. For additional information, please contact Dan McFadden at (425) 753-2105 or ir@sonomapharma.com